Inventor · disambiguated record
Wentian Wang
Also filed as: WANG WENTIAN
6 granted patents·4 pending applications·5 citations·filing 2014–2025
73Inventor score
Top patents by PatentIndex Score
10 records- 0193US11905297B2OX2R compoundsUNIV TEXAS·Filed 2022·Granted Feb 20, 2024·2 cites·24 claims
- 0282US11479560B2OX2R compoundsUNIV TEXAS·Filed 2020·Granted Oct 25, 2022·1 cites·40 claims
- 0382US11472813B2OX2R compoundsUNIV TEXAS·Filed 2020·Granted Oct 18, 2022·1 cites·26 claims
- 0482US2024174685A1OX2R CompoundsUNIV TEXAS·Filed 2024·Application pending·0 cites
- 0573US2025382268A1Methods and compositions for selectively inhibiting pathogenic microbesCFD RES CORPORATION·Filed 2024·Application pending·0 cites
- 0670US2025382269A1Methods and compositions for selectively inhibiting pathogenic microbesCFD RES CORPORATION·Filed 2025·Application pending·0 cites
- 0769US10082496B2Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesisUNIV TEXAS·Filed 2016·Granted Sep 25, 2018·1 cites·19 claims
- 0847US10577344B2Therapeutics targeting truncated adenomatous polyposis coli (APC) proteinsUNIV TEXAS·Filed 2017·Granted Mar 3, 2020·0 cites·31 claims
- 0947US9856233B2Therapeutics targeting truncated adenomatous polyposis coli (APC) proteinsDE BRABANDER JEF·Filed 2014·Granted Jan 2, 2018·0 cites·16 claims
- 1045US2022024891A1Therapeutics targeting mutant adenomatous polyposis coli (apc) for the treatment of cancerUNIV TEXAS·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →